nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—MPO—Cisplatin—peripheral nervous system neoplasm	0.129	0.164	CbGbCtD
Ticlopidine—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.088	0.112	CbGbCtD
Ticlopidine—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0756	0.0962	CbGbCtD
Ticlopidine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.067	0.0852	CbGbCtD
Ticlopidine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0584	0.0743	CbGbCtD
Ticlopidine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0508	0.0646	CbGbCtD
Ticlopidine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0423	0.0538	CbGbCtD
Ticlopidine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0354	0.045	CbGbCtD
Ticlopidine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0338	0.043	CbGbCtD
Ticlopidine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0287	0.0365	CbGbCtD
Ticlopidine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0286	0.0364	CbGbCtD
Ticlopidine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0221	0.0282	CbGbCtD
Ticlopidine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0214	0.0272	CbGbCtD
Ticlopidine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0206	0.0262	CbGbCtD
Ticlopidine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0192	0.0245	CbGbCtD
Ticlopidine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0165	0.021	CbGbCtD
Ticlopidine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0152	0.0193	CbGbCtD
Ticlopidine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00945	0.012	CbGbCtD
Ticlopidine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00929	0.0118	CbGbCtD
Ticlopidine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00866	0.011	CbGbCtD
Ticlopidine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00591	0.00751	CbGbCtD
Ticlopidine—Clopidogrel—ABCB1—peripheral nervous system neoplasm	0.00229	1	CrCbGaD
Ticlopidine—Colitis—Epirubicin—peripheral nervous system neoplasm	0.000422	0.00199	CcSEcCtD
Ticlopidine—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000419	0.00198	CcSEcCtD
Ticlopidine—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000416	0.00197	CcSEcCtD
Ticlopidine—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000416	0.00197	CcSEcCtD
Ticlopidine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000414	0.00196	CcSEcCtD
Ticlopidine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000411	0.00194	CcSEcCtD
Ticlopidine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000411	0.00194	CcSEcCtD
Ticlopidine—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00041	0.00194	CcSEcCtD
Ticlopidine—Pain—Topotecan—peripheral nervous system neoplasm	0.000407	0.00193	CcSEcCtD
Ticlopidine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000405	0.00192	CcSEcCtD
Ticlopidine—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000404	0.00191	CcSEcCtD
Ticlopidine—Pain—Tretinoin—peripheral nervous system neoplasm	0.000404	0.00191	CcSEcCtD
Ticlopidine—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000403	0.0019	CcSEcCtD
Ticlopidine—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.0004	0.00189	CcSEcCtD
Ticlopidine—Pain—Melphalan—peripheral nervous system neoplasm	0.000399	0.00189	CcSEcCtD
Ticlopidine—Ecchymosis—Epirubicin—peripheral nervous system neoplasm	0.000397	0.00188	CcSEcCtD
Ticlopidine—Colitis—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.00184	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000389	0.00184	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000386	0.00183	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000386	0.00183	CcSEcCtD
Ticlopidine—Sepsis—Epirubicin—peripheral nervous system neoplasm	0.000381	0.0018	CcSEcCtD
Ticlopidine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000378	0.00179	CcSEcCtD
Ticlopidine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000378	0.00179	CcSEcCtD
Ticlopidine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000376	0.00178	CcSEcCtD
Ticlopidine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000375	0.00177	CcSEcCtD
Ticlopidine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000375	0.00177	CcSEcCtD
Ticlopidine—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000373	0.00177	CcSEcCtD
Ticlopidine—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000373	0.00177	CcSEcCtD
Ticlopidine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000373	0.00177	CcSEcCtD
Ticlopidine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000373	0.00177	CcSEcCtD
Ticlopidine—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000372	0.00176	CcSEcCtD
Ticlopidine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00037	0.00175	CcSEcCtD
Ticlopidine—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000368	0.00174	CcSEcCtD
Ticlopidine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000368	0.00174	CcSEcCtD
Ticlopidine—Ecchymosis—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.00174	CcSEcCtD
Ticlopidine—Diabetes mellitus—Epirubicin—peripheral nervous system neoplasm	0.000366	0.00173	CcSEcCtD
Ticlopidine—Myalgia—Vincristine—peripheral nervous system neoplasm	0.00036	0.0017	CcSEcCtD
Ticlopidine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000359	0.0017	CcSEcCtD
Ticlopidine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000358	0.00169	CcSEcCtD
Ticlopidine—Vascular purpura—Epirubicin—peripheral nervous system neoplasm	0.000356	0.00168	CcSEcCtD
Ticlopidine—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	0.000355	0.00168	CcSEcCtD
Ticlopidine—Sepsis—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.00167	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000352	0.00166	CcSEcCtD
Ticlopidine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000351	0.00166	CcSEcCtD
Ticlopidine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000351	0.00166	CcSEcCtD
Ticlopidine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000348	0.00165	CcSEcCtD
Ticlopidine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000348	0.00165	CcSEcCtD
Ticlopidine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000345	0.00163	CcSEcCtD
Ticlopidine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000344	0.00162	CcSEcCtD
Ticlopidine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000342	0.00162	CcSEcCtD
Ticlopidine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000341	0.00161	CcSEcCtD
Ticlopidine—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.0016	CcSEcCtD
Ticlopidine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000339	0.0016	CcSEcCtD
Ticlopidine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000339	0.0016	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.000338	0.0016	CcSEcCtD
Ticlopidine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000338	0.0016	CcSEcCtD
Ticlopidine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000337	0.00159	CcSEcCtD
Ticlopidine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000336	0.00159	CcSEcCtD
Ticlopidine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000335	0.00158	CcSEcCtD
Ticlopidine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000334	0.00158	CcSEcCtD
Ticlopidine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000334	0.00158	CcSEcCtD
Ticlopidine—Purpura—Epirubicin—peripheral nervous system neoplasm	0.000331	0.00156	CcSEcCtD
Ticlopidine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00033	0.00156	CcSEcCtD
Ticlopidine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00033	0.00156	CcSEcCtD
Ticlopidine—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.00156	CcSEcCtD
Ticlopidine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000329	0.00156	CcSEcCtD
Ticlopidine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000329	0.00156	CcSEcCtD
Ticlopidine—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.00155	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000326	0.00154	CcSEcCtD
Ticlopidine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000326	0.00154	CcSEcCtD
Ticlopidine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000323	0.00153	CcSEcCtD
Ticlopidine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000323	0.00153	CcSEcCtD
Ticlopidine—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.00032	0.00151	CcSEcCtD
Ticlopidine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000319	0.00151	CcSEcCtD
Ticlopidine—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.000319	0.00151	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000319	0.00151	CcSEcCtD
Ticlopidine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000318	0.0015	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000316	0.00149	CcSEcCtD
Ticlopidine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000315	0.00149	CcSEcCtD
Ticlopidine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000315	0.00149	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000314	0.00149	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.00148	CcSEcCtD
Ticlopidine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000312	0.00148	CcSEcCtD
Ticlopidine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000312	0.00148	CcSEcCtD
Ticlopidine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.00147	CcSEcCtD
Ticlopidine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000306	0.00145	CcSEcCtD
Ticlopidine—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.00145	CcSEcCtD
Ticlopidine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000305	0.00144	CcSEcCtD
Ticlopidine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000305	0.00144	CcSEcCtD
Ticlopidine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000303	0.00143	CcSEcCtD
Ticlopidine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.0003	0.00142	CcSEcCtD
Ticlopidine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.0003	0.00142	CcSEcCtD
Ticlopidine—Rash—Topotecan—peripheral nervous system neoplasm	0.0003	0.00142	CcSEcCtD
Ticlopidine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.0003	0.00142	CcSEcCtD
Ticlopidine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.0003	0.00142	CcSEcCtD
Ticlopidine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000299	0.00141	CcSEcCtD
Ticlopidine—Headache—Topotecan—peripheral nervous system neoplasm	0.000298	0.00141	CcSEcCtD
Ticlopidine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000298	0.00141	CcSEcCtD
Ticlopidine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000298	0.00141	CcSEcCtD
Ticlopidine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000298	0.00141	CcSEcCtD
Ticlopidine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000298	0.00141	CcSEcCtD
Ticlopidine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000296	0.0014	CcSEcCtD
Ticlopidine—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.0014	CcSEcCtD
Ticlopidine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000296	0.0014	CcSEcCtD
Ticlopidine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000296	0.0014	CcSEcCtD
Ticlopidine—Pain—Vincristine—peripheral nervous system neoplasm	0.000295	0.0014	CcSEcCtD
Ticlopidine—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.00139	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.00139	CcSEcCtD
Ticlopidine—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000294	0.00139	CcSEcCtD
Ticlopidine—Rash—Melphalan—peripheral nervous system neoplasm	0.000294	0.00139	CcSEcCtD
Ticlopidine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000294	0.00139	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000293	0.00138	CcSEcCtD
Ticlopidine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000291	0.00138	CcSEcCtD
Ticlopidine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000284	0.00135	CcSEcCtD
Ticlopidine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000284	0.00134	CcSEcCtD
Ticlopidine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000283	0.00134	CcSEcCtD
Ticlopidine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000283	0.00134	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000282	0.00133	CcSEcCtD
Ticlopidine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000281	0.00133	CcSEcCtD
Ticlopidine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000281	0.00133	CcSEcCtD
Ticlopidine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000279	0.00132	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000278	0.00131	CcSEcCtD
Ticlopidine—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000277	0.00131	CcSEcCtD
Ticlopidine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000277	0.00131	CcSEcCtD
Ticlopidine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000277	0.00131	CcSEcCtD
Ticlopidine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000274	0.00129	CcSEcCtD
Ticlopidine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000273	0.00129	CcSEcCtD
Ticlopidine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000273	0.00129	CcSEcCtD
Ticlopidine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.00129	CcSEcCtD
Ticlopidine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000266	0.00126	CcSEcCtD
Ticlopidine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000265	0.00125	CcSEcCtD
Ticlopidine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000264	0.00125	CcSEcCtD
Ticlopidine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000264	0.00125	CcSEcCtD
Ticlopidine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000262	0.00124	CcSEcCtD
Ticlopidine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000261	0.00123	CcSEcCtD
Ticlopidine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000257	0.00121	CcSEcCtD
Ticlopidine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.00121	CcSEcCtD
Ticlopidine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000254	0.0012	CcSEcCtD
Ticlopidine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000253	0.0012	CcSEcCtD
Ticlopidine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.00119	CcSEcCtD
Ticlopidine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000248	0.00117	CcSEcCtD
Ticlopidine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000246	0.00116	CcSEcCtD
Ticlopidine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000245	0.00116	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000244	0.00115	CcSEcCtD
Ticlopidine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000243	0.00115	CcSEcCtD
Ticlopidine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000243	0.00115	CcSEcCtD
Ticlopidine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.00114	CcSEcCtD
Ticlopidine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000241	0.00114	CcSEcCtD
Ticlopidine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000241	0.00114	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000241	0.00114	CcSEcCtD
Ticlopidine—Pain—Etoposide—peripheral nervous system neoplasm	0.000239	0.00113	CcSEcCtD
Ticlopidine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000237	0.00112	CcSEcCtD
Ticlopidine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000236	0.00112	CcSEcCtD
Ticlopidine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000234	0.00111	CcSEcCtD
Ticlopidine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000232	0.0011	CcSEcCtD
Ticlopidine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000229	0.00108	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000229	0.00108	CcSEcCtD
Ticlopidine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000228	0.00108	CcSEcCtD
Ticlopidine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000228	0.00108	CcSEcCtD
Ticlopidine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000226	0.00107	CcSEcCtD
Ticlopidine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000226	0.00107	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.00107	CcSEcCtD
Ticlopidine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000225	0.00106	CcSEcCtD
Ticlopidine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000224	0.00106	CcSEcCtD
Ticlopidine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.00106	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.00105	CcSEcCtD
Ticlopidine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000222	0.00105	CcSEcCtD
Ticlopidine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000222	0.00105	CcSEcCtD
Ticlopidine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000221	0.00104	CcSEcCtD
Ticlopidine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.00022	0.00104	CcSEcCtD
Ticlopidine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00022	0.00104	CcSEcCtD
Ticlopidine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000219	0.00104	CcSEcCtD
Ticlopidine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000219	0.00103	CcSEcCtD
Ticlopidine—Rash—Vincristine—peripheral nervous system neoplasm	0.000218	0.00103	CcSEcCtD
Ticlopidine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000217	0.00103	CcSEcCtD
Ticlopidine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.00102	CcSEcCtD
Ticlopidine—Headache—Vincristine—peripheral nervous system neoplasm	0.000216	0.00102	CcSEcCtD
Ticlopidine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.00101	CcSEcCtD
Ticlopidine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000213	0.00101	CcSEcCtD
Ticlopidine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000209	0.000987	CcSEcCtD
Ticlopidine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000986	CcSEcCtD
Ticlopidine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000206	0.000974	CcSEcCtD
Ticlopidine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000972	CcSEcCtD
Ticlopidine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.00097	CcSEcCtD
Ticlopidine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000205	0.000969	CcSEcCtD
Ticlopidine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000965	CcSEcCtD
Ticlopidine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000965	CcSEcCtD
Ticlopidine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000201	0.000948	CcSEcCtD
Ticlopidine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000198	0.000935	CcSEcCtD
Ticlopidine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000194	0.000917	CcSEcCtD
Ticlopidine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000912	CcSEcCtD
Ticlopidine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000192	0.00091	CcSEcCtD
Ticlopidine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000192	0.000909	CcSEcCtD
Ticlopidine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000191	0.000904	CcSEcCtD
Ticlopidine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.0009	CcSEcCtD
Ticlopidine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000894	CcSEcCtD
Ticlopidine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000185	0.000874	CcSEcCtD
Ticlopidine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000873	CcSEcCtD
Ticlopidine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000181	0.000857	CcSEcCtD
Ticlopidine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000178	0.00084	CcSEcCtD
Ticlopidine—Rash—Etoposide—peripheral nervous system neoplasm	0.000176	0.000833	CcSEcCtD
Ticlopidine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000176	0.000832	CcSEcCtD
Ticlopidine—Headache—Etoposide—peripheral nervous system neoplasm	0.000175	0.000828	CcSEcCtD
Ticlopidine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000828	CcSEcCtD
Ticlopidine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000807	CcSEcCtD
Ticlopidine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000166	0.000785	CcSEcCtD
Ticlopidine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000773	CcSEcCtD
Ticlopidine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000773	CcSEcCtD
Ticlopidine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000741	CcSEcCtD
Ticlopidine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000725	CcSEcCtD
Ticlopidine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000715	CcSEcCtD
Ticlopidine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000715	CcSEcCtD
Ticlopidine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000706	CcSEcCtD
Ticlopidine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000685	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000675	CcSEcCtD
Ticlopidine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000671	CcSEcCtD
Ticlopidine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000653	CcSEcCtD
Ticlopidine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000652	CcSEcCtD
Ticlopidine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000644	CcSEcCtD
Ticlopidine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000633	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000624	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000606	CcSEcCtD
Ticlopidine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000603	CcSEcCtD
Ticlopidine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000596	CcSEcCtD
Ticlopidine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000588	CcSEcCtD
Ticlopidine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000586	CcSEcCtD
Ticlopidine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000586	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00056	CcSEcCtD
Ticlopidine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000546	CcSEcCtD
Ticlopidine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000545	CcSEcCtD
Ticlopidine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000542	CcSEcCtD
Ticlopidine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000531	CcSEcCtD
Ticlopidine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000524	CcSEcCtD
Ticlopidine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000507	CcSEcCtD
Ticlopidine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000505	CcSEcCtD
Ticlopidine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000492	CcSEcCtD
Ticlopidine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000104	0.00049	CcSEcCtD
Ticlopidine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000485	CcSEcCtD
Ticlopidine—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.96e-05	0.000471	CcSEcCtD
Ticlopidine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	9.92e-05	0.000469	CcSEcCtD
Ticlopidine—Rash—Epirubicin—peripheral nervous system neoplasm	9.88e-05	0.000467	CcSEcCtD
Ticlopidine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	9.87e-05	0.000467	CcSEcCtD
Ticlopidine—Headache—Epirubicin—peripheral nervous system neoplasm	9.81e-05	0.000464	CcSEcCtD
Ticlopidine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.58e-05	0.000453	CcSEcCtD
Ticlopidine—Nausea—Epirubicin—peripheral nervous system neoplasm	9.3e-05	0.00044	CcSEcCtD
Ticlopidine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	9.22e-05	0.000436	CcSEcCtD
Ticlopidine—Rash—Doxorubicin—peripheral nervous system neoplasm	9.14e-05	0.000432	CcSEcCtD
Ticlopidine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	9.13e-05	0.000432	CcSEcCtD
Ticlopidine—Headache—Doxorubicin—peripheral nervous system neoplasm	9.08e-05	0.000429	CcSEcCtD
Ticlopidine—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.61e-05	0.000407	CcSEcCtD
